| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881113 | The Annals of Thoracic Surgery | 2007 | 8 Pages |
Abstract
Thirty-day respiratory support was feasible with the Biolung, but improvements in biocompatibility and anticoagulation regimen are warranted to reduce the thrombogenicity of the device.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hitoshi MD, Candice M. BS, LVT, Nathan G. BS, Joshua R. BS, Niru MD, John M. MS, Jonathan W. MD, Keith E. PhD,